Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics in Multiple Sclerosis: The Perspective of the Clinician. | Int J Mol Sci | 2022 | 35563559 | PubTator, text mining | PubMed |
| Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride. | Allergy Asthma Clin Immunol | 2022 | 35562767 | PubTator, text mining | PubMed |
| Comprehensive Characterization of Arterial and Cardiac Function in Marfan Syndrome-Can Biomarkers Help Improve Outcome? | Front Physiol | 2022 | 35547588 | PubTator, text mining | PubMed |
| Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase. | J Virol | 2022 | 35543552 | PubTator, text mining | PubMed |
| Potentially inappropriate medications for patients with heart failure and risk of hospitalization from heart failure: A case-control study from Thailand. | Pharm Pract (Granada) | 2022 | 35497905 | PubTator, text mining | PubMed |
| Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials. | Int Immunopharmacol | 2022 | 35483235 | PubTator, text mining | PubMed |
| Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer's Disease: A Retrospective Inception Cohort Study. | J Alzheimers Dis | 2022 | 35466934 | PubTator, text mining | PubMed |
| Long-Term Effect of β-Blocker Use on Clinical Outcomes in Postmyocardial Infarction Patients: A Systematic Review and Meta-Analysis. | Front Cardiovasc Med | 2022 | 35463744 | PubTator, text mining | PubMed |
| Impact of the CYP2D6 Genotype on Metoprolol Tolerance and Adverse Events in Elderly Chinese Patients With Cardiovascular Diseases. | Front Pharmacol | 2022 | 35462926 | PubTator, text mining | PubMed |
| A Network Pharmacology Based Research on the Mechanism of Donepezil in Treating Alzheimer's Disease. | Front Aging Neurosci | 2022 | 35462691 | PubTator, text mining | PubMed |
| Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects. | NPJ Syst Biol Appl | 2022 | 35443763 | PubTator, text mining | PubMed |
| Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1. | J Clin Invest | 2022 | 35439173 | PubTator, text mining | PubMed |
| Epoxiconazole alters the histology and transcriptome of mouse liver in a transgenerational pattern. | Chem Biol Interact | 2022 | 35436446 | PubTator, text mining | PubMed |
| Remediation of pharmaceuticals from contaminated water by molecularly imprinted polymers: a review. | Environ Chem Lett | 2022 | 35431714 | PubTator, text mining | PubMed |
| A systematic review and functional bioinformatics analysis of genes associated with Crohn's disease identify more than 120 related genes. | BMC Genomics | 2022 | 35418025 | PubTator, text mining | PubMed |
| DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma. | BMC Pulm Med | 2022 | 35392867 | PubTator, text mining | PubMed |
| Biology and Treatment of Richter Transformation. | Front Oncol | 2022 | 35392219 | PubTator, text mining | PubMed |
| Immune Subtypes Characterization Identifies Clinical Prognosis, Tumor Microenvironment Infiltration, and Immune Response in Ovarian Cancer. | Front Mol Biosci | 2022 | 35386298 | PubTator, text mining | PubMed |
| Structure of S1PR2-heterotrimeric G13 signaling complex. | Sci Adv | 2022 | 35353559 | PubTator, text mining | PubMed |
| Genetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery. | Yonsei Med J | 2022 | 35352885 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=17